# GAVRETO
> **NDA214701** · New Drug Application · Sponsor: BLUEPRINT MEDICINES · Approved 2020-12-01
## Drug
- **FDA Application Number:** NDA214701
- **Application type:** New Drug Application
- **Brand name:** GAVRETO
- **Generic name:** Pralsetinib
- **Active ingredients:** PRALSETINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BLUEPRINT MEDICINES
- **First approval:** 2020-12-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214701)
---
*AI Analytics · CC0 1.0*